<DOC>
	<DOCNO>NCT00432211</DOCNO>
	<brief_summary>This study undertaken investigate efficacy safety Juvista ( give intradermal injection 200ng/100Âµl per linear centimetre wound margin ) prevention improvement scar appearance administer intradermally approximate wound margin follow surgical scar revision . In addition , study compare scar revision technique complete excision ( excision entire scar one surgical procedure ) stag excision ( excision outmost segment central core separately ) .</brief_summary>
	<brief_title>Juvista ( Avotermin ) Prevention Improvement Scar Appearance Following Scar Revision Surgery .</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<criteria>Subjects age 1885 year provide write informed consent . A body mass index 15 35 kg/m2 . Subjects , opinion Investigator , clinically acceptable result laboratory test specify trial protocol . Female subject child bear potential use method ( ) contraception acceptable Investigator agree least screening visit one month administration final study dose . Subjects linear scar , opinion Investigator , suitable revision excision direct closure . The area scar revise must least 5cm length least two comparable area . Subjects , , opinion Investigator stabilise , mature scar . Subjects direct question physical examination history evidence keloid scar . Subjects scar revision cross joint close proximity anatomical structure , could lead distortion resultant scar . Subjects additional scar le 3cm away area revise . Subjects history bleed disorder . Subjects diseases condition could , opinion Investigator , interfere assessment safety , tolerability efficacy . Subjects surgery area excise within one year Day 0 . Subjects skin disorder chronic currently active Investigator considers adversely affect heal acute wound involve area examine trial . Subjects direct question / physical examination , evidence past present clinically significant medical condition would impair wound heal . Subjects history clinically significant hypersensitivity drug surgical dressing use trial . Subjects take , take , investigational drug include Juvista within 3 month prior screen visit . Subjects take regular , continuous , oral corticosteroid therapy . Subjects , opinion Investigator , significant ongoing psychiatric disorder , may interfere trial assessment / visit . Subjects undergoing investigation change management exist medical condition . Subjects become pregnant include Day 0 lactating . In opinion Investigator , subject likely complete trial whatever reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>